Biblio
ABCB5 mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa. Cytotherapy. 2023.
Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects and modulate mRNA expression in a cisplatin-induced kidney injury murine model. Front Immunol. 2023;14:1228928.
. Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782-788/1562]. Cytotherapy. 2023;25(9):1016.
Protocol for isolating human BCAM-positive corneal progenitor cells by flow cytometry and cell sorting. STAR Protoc. 2023;4(3):102503.
. Angiogenin Released from ABCB5 Stromal Precursors Improves Healing of Diabetic Wounds by Promoting Angiogenesis. J Invest Dermatol. 2021.
. . Restoring the cornea from limbal stem cells. Regen Med. 2015;10(1):1-4.
.